| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.054 | 0.6 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |